Skip to content

    Phathom Pharmaceuticals (PHAT) stock price & financials

    View PHAT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance26.2% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $16.35M
    $29.66M
    $28.52M
    $39.50M
    $49.50M
    +202.7%
    $57.58M
    +94.1%
    $58.30M
    +104.4%
    $74.27M
    +88.0%
    Strengthening
    Operating Profit
    -$70.80M
    -$59.42M
    -$78.86M
    -$59.92M
    -$15.27M
    +78.4%
    -$5.93M
    +90.0%
    -$15.48M
    +80.4%
    -$3.96M
    +93.4%
    Strengthening
    Net Profit
    -$85.58M
    -$74.45M
    -$94.32M
    -$75.81M
    -$29.97M
    +65.0%
    -$21.15M
    +71.6%
    -$30.37M
    +67.8%
    -$17.58M
    +76.8%
    Strengthening
    EPS
    $-1.32
    $-1.31
    $-1.05
    $-0.41
    +68.9%
    $-0.37
    +71.8%
    $-0.21
    +80.0%
    Strengthening
    Other Income
    -$14.78M
    -$15.03M
    -$15.45M
    -$15.89M
    -$14.70M
    +0.5%
    -$15.22M
    -1.2%
    -$14.89M
    +3.6%
    -$13.62M
    +14.3%
    Strengthening
    Interest
    $18.48M
    $18.59M
    $18.07M
    $17.52M
    $16.11M
    -12.9%
    $16.42M
    -11.7%
    $15.80M
    -12.6%
    $15.10M
    -13.8%
    Weakening
    Depreciation
    Profit before Tax
    MarginsOPM
    -432.9%
    -200.3%
    -276.5%
    -151.7%
    -30.9%
    +92.9%
    -10.3%
    +94.9%
    -26.6%
    +90.4%
    -5.3%
    +96.5%
    Strengthening
    Tax
    ReturnsROIC
    5.6%
    4.9%
    6.2%
    4.9%
    2.0%
    -65.0%
    1.4%
    -71.6%
    2.0%
    -67.8%
    1.1%
    -76.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$879.0K$243.76M$287.50M$183.26M$155.38M$381.39M$297.26M$129.97M$182.48M
    Short-Term Investments
    Total Current Assets$902.0K$255.60M$291.37M$186.53M$160.51M$397.43M$360.13M$228.97M$295.92M
    Net PP&E$1.40M$3.36M$2.56M$3.49M$3.62M$2.09M$3.67M$3.38M
    Goodwill
    Intangibles
    Total Assets$902.0K$257.18M$295.11M$189.43M$164.81M$413.84M$378.32M$259.15M$327.07M
    LiabilitiesTotal Current Liabilities$2.19M$3.75M$55.52M$18.92M$26.24M$38.78M$85.73M$132.04M$153.78M
    Short-Term Debt$7.35M$0$0$0$0$0
    Long-Term Debt$22.78M$39.63M$89.67M$95.26M$137.84M$201.41M$209.09M$164.59M
    Long-Term Leases$635.0K$1.56M$1.18M$1.10M$462.0K$0$2.06M$1.85M
    Total Liabilities$2.19M$29.22M$100.84M$117.28M$239.62M$486.60M$631.90M$697.32M$671.35M
    EquityCommon Stock & APIC$2.0K$3.0K$3.0K$3.0K$5.0K$6.0K$6.0K$8.0K
    Retained Earnings-$1.29M-$256.42M-$385.49M-$529.37M-$727.09M-$928.68M-$1.26B-$1.48B-$1.53B
    Total Equity-$1.29M$227.96M$194.27M$72.16M-$74.81M-$72.76M-$253.58M-$438.17M-$344.27M
    HighlightsNet Cash / (Debt)$240.51M$60.12M$243.55M$95.85M-$79.11M$17.89M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$1.02M-$36.51M-$69.69M-$148.46M-$146.53M-$137.58M-$266.77M-$166.78M-$36.69M
    Cash from Investing-$25.25M-$1.04M-$328.0K-$1.04M-$1.63M-$135.0K-$229.0K-$219.0K
    Cash from Financing$1.90M$304.65M$114.46M$44.71M$120.04M$367.58M$182.77M-$288.0K$69.82M
    SummaryCapital Expenditure-$132.0K-$1.04M-$328.0K-$1.04M-$1.63M-$135.0K-$229.0K-$219.0K
    Free Cash Flow-$36.64M-$70.73M-$148.78M-$147.57M-$139.21M-$266.90M-$167.00M-$36.91M
    FCF Margin-20412.6%-483.1%-95.4%-15.4%

    Ratios